Shopping Cart
- Remove All
Your shopping cart is currently empty
SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $35 | In Stock | |
| 5 mg | $58 | In Stock | |
| 10 mg | $88 | In Stock | |
| 25 mg | $178 | In Stock | |
| 50 mg | $287 | In Stock | |
| 100 mg | $413 | In Stock | |
| 200 mg | $593 | In Stock |
| Description | SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma. |
| In vivo | In Guinea pigs, intravenous injection of SR2640 (1 mg/kg) prevents the contractile responses of the ileum and trachea to leukotriene D4 and E4[1]. |
| Molecular Weight | 406.86 |
| Formula | C23H19ClN2O3 |
| Cas No. | 146662-42-2 |
| Smiles | Cl.OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225.0 mg/mL (553.0 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (12.29 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.